These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1788805)

  • 1. [The problems of modern transfusion science].
    Vorob'ev AI; Dabberkha NM
    Ter Arkh; 1991; 63(7):4-9. PubMed ID: 1788805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 3. [Everyone and nobody has the responsibility for the future of plasma products].
    Sjölin S
    Lakartidningen; 1996 Nov; 93(46):4137, 4139. PubMed ID: 8984263
    [No Abstract]   [Full Text] [Related]  

  • 4. Panel Discussion. Millennium Festival of Medicine--Transfusion 2020--18 October 2000.
    Fogden M; Whitehorn K; Starr D; Persaud R; Hannaford R; Barbara J; Love E; Robinson A; Ferguson E; Turner G; Wallington T; Klein H; Franklin I; Fry R
    Transfus Med; 2001 Apr; 11(2):136-45. PubMed ID: 11583001
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustaining life twice. Will umbilical cord blood replace bone marrow?
    Breton JH
    Adv Nurse Pract; 2000 Mar; 8(3):92, 95-6, 108. PubMed ID: 11107358
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood component therapy today].
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Sirchia G
    Haematologica; 1991 Jun; 76 Suppl 3():405-10. PubMed ID: 1752540
    [No Abstract]   [Full Text] [Related]  

  • 7. Current practices in transfusion medicine.
    Borker A; Warrier RP
    Indian Pediatr; 2001 Mar; 38(3):227-30. PubMed ID: 11255297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern problems of transfusion-infusion therapy].
    Kolesnikov IS; Ryzhkov SV
    Voen Med Zh; 1977 Nov; (11):38-41. PubMed ID: 339522
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
    Gyopar AF; Loertscher R; Guttman RD; Tchervenkov JI
    Transplantation; 1993 May; 55(5):1199-202. PubMed ID: 8497904
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivation of pathogens in blood and blood products.
    Ben-Hur E
    Med Health R I; 1998 Dec; 81(12):396-9. PubMed ID: 9884539
    [No Abstract]   [Full Text] [Related]  

  • 11. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.
    Goodrich RP; Edrich RA; Li J; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):5-17. PubMed ID: 16935562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next century's academic clinical research development in blood and marrow transplants requires continental organizational development.
    Van Hoef ME
    Bone Marrow Transplant; 1999 Dec; 24(11):1265. PubMed ID: 10642821
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreasing the risk of allogenic blood in the 21st century.
    Popovsky MA; O'Neill EM; Cannon M
    Med Health R I; 1998 Dec; 81(12):392-5. PubMed ID: 9884538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rational substitution with stored blood and blood components].
    Krüger KJ; Gürtler LG
    Dtsch Med Wochenschr; 1995 Apr; 120(17):627-8. PubMed ID: 7736963
    [No Abstract]   [Full Text] [Related]  

  • 15. Fifty years of blood transfusion.
    Gunson HH; Dodsworth H
    Transfus Med; 1996; 6 Suppl 1():1-88. PubMed ID: 8870182
    [No Abstract]   [Full Text] [Related]  

  • 16. Passage to India.
    Kiser K
    Minn Med; 2007 Mar; 90(3):10-1. PubMed ID: 17432747
    [No Abstract]   [Full Text] [Related]  

  • 17. [The safety of blood and blood products].
    Löwer J
    Internist (Berl); 1994 Oct; 35(10):929-33. PubMed ID: 8002228
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood and marrow transplant: it's not just for cancer.
    Eisenberg S
    ONS Connect; 2012 Nov; 27(11):22. PubMed ID: 23316526
    [No Abstract]   [Full Text] [Related]  

  • 19. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tests for donors of blood and bone marrow].
    Taniwaki K; Itoh M; Misawa M; Hara H
    Rinsho Byori; 1995 Jul; Suppl 99():102-10. PubMed ID: 7474414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.